.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Harvard Business School
Citi
AstraZeneca
Healthtrust
Accenture
US Department of Justice
Moodys
Federal Trade Commission
Deloitte

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for Biologics License Application 103353

« Back to Dashboard

Summary for BLA: 103353

Tradename:
NEUPOGEN
Applicant:
Amgen
Ingredient:
filgrastim
Patents:139
Approval Date:Feb 20, 1991
Suppliers: see list2
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Amgen
NEUPOGEN
filgrastim
VIAL1033530011991-02-204,810,643 Kirin- Amgen Inc. (Thousand Oaks, CA) Souza; Lawrence M. (Thousand Oaks, CA) ► SubscribeRXcompany
Amgen
NEUPOGEN
filgrastim
VIAL1033530021991-02-204,810,643 Kirin- Amgen Inc. (Thousand Oaks, CA) Souza; Lawrence M. (Thousand Oaks, CA) ► SubscribeRXcompany
Amgen
NEUPOGEN
filgrastim
SYRINGE1033530031991-02-204,810,643 Kirin- Amgen Inc. (Thousand Oaks, CA) Souza; Lawrence M. (Thousand Oaks, CA) ► SubscribeRXcompany
Amgen
NEUPOGEN
filgrastim
SYRINGE1033530041991-02-204,810,643 Kirin- Amgen Inc. (Thousand Oaks, CA) Souza; Lawrence M. (Thousand Oaks, CA) ► SubscribeRXcompany
Amgen
NEUPOGEN
filgrastim
VIAL1033530011991-02-204,999,291 Amgen Inc. (Thousand Oaks, CA) Souza; Lawrence M. (Thousand Oaks, CA) ► SubscribeRXcompany
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Covington
Cantor Fitzgerald
Moodys
Mallinckrodt
Merck
Harvard Business School
Novartis
Federal Trade Commission
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot